INVO logo

INVO Bioscience (INVO) Accounts Receivable

Annual Accounts Receivable

$140.60 K
+$63.50 K+82.36%

December 31, 2023

Summary

Performance

1-Year Change

+82.36%

3-Year Change

+547.93%

5-Year Change

-37.76%

15-Year Change

+62.17%

INVO Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$225.90 K
INVO annual accounts receivable is currently -37.76% below its historical high of $225.90 thousand

3-Year Low

$50.50 K
INVO annual accounts receivable is currently +178.42% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
INVO next annual earnings announcement has not yet been scheduled

OtherINVObalance sheetmetrics:

Annual Accounts Payable

$2.33 M
INVO annual accounts payable is $2.33 million

Annual Total Assets

$20.89 M
INVO annual total assets is $20.89 million

Annual Total Liabilities

$20.00 M
INVO annual total liabilities is $20.00 million

Annual Cash & Cash Equivalents

$232.40 K
INVO annual cash & cash equivalents is $232.40 thousand

Quarterly Accounts Receivable

$257.05 K
-$149.00-0.06%

September 30, 2024

Summary

Performance

3-Month Change

-0.06%

1-Year Change

+45.31%

3-Year Change

+337.91%

5-Year Change

+337.91%

INVO Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$527.70 K
INVO quarterly accounts receivable is currently -51.29% below its historical high of $527.70 thousand

3-Year Low

$50.50 K
INVO quarterly accounts receivable is currently +409.01% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVObalance sheetmetrics:

Quarterly Accounts Payable

-
INVO quarterly accounts payable value is unknown

Quarterly Total Assets

$17.02 M
INVO quarterly total assets is $17.02 million

Quarterly Total Liabilities

$17.04 M
INVO quarterly total liabilities is $17.04 million

Quarterly Cash And Cash Equivalents

$471.59 K
INVO quarterly cash and cash equivalents is $471.59 thousand

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

INVO Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+82.4%+45.3%
3 y3 years+547.9%+337.9%
5 y5 years-37.8%+337.9%

INVO Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-64.1%-0.1%-80.4%
5 y5-yearat high-94.6%-51.3%-98.6%
alltimeall time-37.8%-99.8%-51.3%-99.5%

INVO Bioscience Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$257.05 K(-0.1%)
Jun 2024
-
$257.20 K(+45.4%)
Mar 2024
-
$176.90 K(+25.8%)
Dec 2023
$140.60 K(+82.4%)
$140.60 K(+20.4%)
Sep 2023
-
$116.80 K(+55.9%)
Jun 2023
-
$74.90 K(-24.9%)
Mar 2023
-
$99.70 K(+29.3%)
Dec 2022
$77.10 K(+52.7%)
$77.10 K(+8.1%)
Sep 2022
-
$71.30 K(+26.2%)
Jun 2022
-
$56.50 K(-3.7%)
Mar 2022
-
$58.70 K(+16.2%)
Dec 2021
$50.50 K(+132.7%)
$50.50 K(-0.4%)
Sep 2021
-
$50.70 K(+5.8%)
Jun 2021
-
$47.90 K(-90.9%)
Mar 2021
-
$527.70 K(+2331.8%)
Dec 2020
$21.70 K(+185.5%)
$21.70 K(+486.5%)
Sep 2020
-
$3700.00(-94.8%)
Jun 2020
-
$71.20 K(+1824.3%)
Mar 2020
-
$3700.00(-51.3%)
Dec 2019
$7600.00(-96.6%)
$7600.00(-71.9%)
Sep 2019
-
$27.00 K(-88.8%)
Jun 2019
-
$240.20 K(+221.6%)
Mar 2019
-
$74.70 K(-66.9%)
Dec 2018
$225.90 K
$225.90 K(+20.7%)
Sep 2018
-
$187.10 K(+34.2%)
Jun 2018
-
$139.40 K(+25.7%)
DateAnnualQuarterly
Mar 2018
-
$110.90 K(+27.9%)
Dec 2017
$86.70 K(+2996.4%)
$86.70 K(+44.0%)
Sep 2017
-
$60.20 K(+40.0%)
Jun 2017
-
$43.00 K(+33.1%)
Mar 2017
-
$32.30 K(+1053.6%)
Dec 2016
$2800.00(+115.4%)
$2800.00(-71.1%)
Sep 2016
-
$9700.00(-46.7%)
Jun 2016
-
$18.20 K(+0.6%)
Mar 2016
-
$18.10 K(+1292.3%)
Dec 2015
$1300.00(+333.3%)
$1300.00(-76.8%)
Dec 2014
$300.00(-83.3%)
-
Dec 2013
$1800.00(-85.6%)
-
Dec 2012
$12.50 K(+123.2%)
-
Dec 2011
$5600.00(-64.3%)
$5600.00(-40.4%)
Sep 2011
-
$9400.00(-32.4%)
Jun 2011
-
$13.90 K(-12.6%)
Mar 2011
-
$15.90 K(+1.3%)
Dec 2010
$15.70 K(+406.5%)
$15.70 K(+103.9%)
Sep 2010
-
$7700.00(-72.0%)
Jun 2010
-
$27.50 K(+6.2%)
Mar 2010
-
$25.90 K(+735.5%)
Dec 2009
$3100.00(-90.9%)
$3100.00(-95.4%)
Sep 2009
-
$66.90 K(+2.1%)
Jun 2009
-
$65.50 K(+25.2%)
Mar 2009
-
$52.30 K(+52.9%)
Dec 2008
$34.20 K
$34.20 K

FAQ

  • What is INVO Bioscience annual accounts receivable?
  • What is the all time high annual accounts receivable for INVO Bioscience?
  • What is INVO Bioscience annual accounts receivable year-on-year change?
  • What is INVO Bioscience quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for INVO Bioscience?
  • What is INVO Bioscience quarterly accounts receivable year-on-year change?

What is INVO Bioscience annual accounts receivable?

The current annual accounts receivable of INVO is $140.60 K

What is the all time high annual accounts receivable for INVO Bioscience?

INVO Bioscience all-time high annual accounts receivable is $225.90 K

What is INVO Bioscience annual accounts receivable year-on-year change?

Over the past year, INVO annual accounts receivable has changed by +$63.50 K (+82.36%)

What is INVO Bioscience quarterly accounts receivable?

The current quarterly accounts receivable of INVO is $257.05 K

What is the all time high quarterly accounts receivable for INVO Bioscience?

INVO Bioscience all-time high quarterly accounts receivable is $527.70 K

What is INVO Bioscience quarterly accounts receivable year-on-year change?

Over the past year, INVO quarterly accounts receivable has changed by +$80.15 K (+45.31%)